SLDB financials
Solid Biosciences (SLDB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SLDB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$179.21M | -$174.32M | -1.99 |
| 2024 | – | – | -$129.73M | -$124.70M | -3.06 |
| 2023 | – | – | -$104.25M | -$96.02M | -4.83 |
| 2022 | $8.09M | – | -$106.45M | -$85.98M | -10.10 |
| 2021 | $13.62M | – | -$72.25M | -$72.19M | -10.14 |
| 2020 | $0.00 | – | -$88.41M | -$88.29M | -25.50 |